Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases [Phase 4]
Phase 4 clinical trial update evaluating intradermal Tozinameran (COVID-19 vaccine) in patients with immune-mediated dermatologic diseases.
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants [Phase 1]
A Phase 1 clinical trial evaluating the safety and potential benefit of GSK2982772 in moderate to severe psoriasis has completed with result…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis [Phase 3]
Phase 3 trial results (efficacy and safety) for brodalumab in adolescents aged 12 to 17 with moderate-to-severe plaque psoriasis; the study …
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors [Phase 2]
Phase 2 proof-of-activity study of Orticumab in subjects with psoriasis and cardiometabolic risk factors completed.
-
CLINICAL_TRIALS trial_result · 2024-01-29Clinical Trial Update: A Study of Mirikizumab in Participants With Plaque Psoriasis [Phase 1]
A Phase 1 clinical trial of mirikizumab in participants with plaque psoriasis has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 clinical trial evaluating IBI112 for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial comparing subcutaneous DMB-3115 to Stelara in moderate to severe chronic plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial updates for Hemay005 in moderate to severe plaque psoriasis have been completed.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial update on the interchangeability of ABP 654 for moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis [NA]
Pilot study assessing the effect of nicotinamide riboside on immune activation in psoriasis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-19Clinical Trial Update: A Study of QY101 Ointment in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update for QY101 ointment in subjects with psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215) [Phase 2]
Phase 2 trial assessing pharmacokinetics and safety of ARQ-151 in children with plaque psoriasis completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects [Phase 3]
Phase 3 bioequivalence study of two Apremilast 30 mg tablet products completed in healthy adults.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update evaluating HS-10374 for moderate to severe plaque psoriasis to assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2 trial of cedirogant (ABBV-157) in adults with moderate to severe psoriasis was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LZM012 [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of LZM012 for psoriasis is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2023-10-27Clinical Trial Update: Vtama in Psoriasis Patients Being Treated With Biologics. [Phase 4]
Phase 4 clinical trial update for Vtama in patients with psoriasis who are being treated with biologics.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 clinical trial of guselkumab in Chinese participants with moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial of NDI-034858 in moderate to severe plaque psoriasis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 [Phase 1]
A Phase 1 trial evaluating tolerability of varying doses of BI 730357 in healthy men and how BI 730357 affects the metabolism of midazolam, …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Efficacy and Safety of Infliximab Biosimilar Remsima in Psoriasis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of the infliximab biosimilar Remsima in psoriasis.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis [Phase 1]
Phase 1 clinical trial update for LY3316531 in healthy participants and psoriasis patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Efficacy and Safety of Apremilast in Psoriasis [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of apremilast in psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating safety and efficacy of expanded allogeneic adipose-derived mesenchymal stromal cells in pati…
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis [Phase 1, Phase 2]
A Phase 1/2 clinical trial comparing PSORI-CM01 formula to Gu Ben Hua Yu formula combined with AD-MSCs in psoriasis is underway, with an unk…